Have data from 23andMe or Ancestry? Make a report automatically with Promethease !

rs1800460

From SNPedia

Orientationminus
Stabilizedminus
Geno Mag Summary
(A;A) 3.5 incapable of detoxifying byproducts of certain drugs
(A;G) 3 (TPMT*3B) impaired drug metabolism
(G;G) 0 normal
ReferenceGRCh38 38.1/142
Chromosome6
Position18138997
GeneTPMT
is asnp
is mentioned by
dbSNPrs1800460
dbSNP (old)rs1800460
ClinGenrs1800460
ebirs1800460
HLIrs1800460
Exacrs1800460
Gnomadrs1800460
Varsomers1800460
Maprs1800460
PheGenIrs1800460
Biobankrs1800460
1000 genomesrs1800460
hgdprs1800460
ensemblrs1800460
gopubmedrs1800460
geneviewrs1800460
scholarrs1800460
googlers1800460
pharmgkbrs1800460
gwascentralrs1800460
openSNPrs1800460
23andMers1800460
23andMe allrs1800460
SNPshotrs1800460
SNPdbers1800460
MSV3drs1800460
GWAS Ctlgrs1800460
GMAF0.01699
Max Magnitude3.5
Error creating thumbnail: Unable to save thumbnail to destination

This SNP has been recognized by the Coriell Personalized Medicine Collaborative ICOB.
Additional information is available here

rs1800460 is a SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs. In general, individuals must have two nonfunctioning TPMT alleles for the toxicity to be pronounced.

The risk allele for this SNP is rs1800460(A), and when it is the only variation in the TPMT gene, it encodes the TPMT*3B allele. While still rare, it is more common in Caucasians (4.5% of all alleles) than in African-Americans (0.8%). Note that if the same allele also carries the rs1142345(G) SNP, the allele is actually a TPMT*3A allele (OMIM).

The medicine 6-Mercaptopurine is metabolized by TPMT. Individual differences in TPMT activity associated with this SNP are now used to determine appropriate dosage range and interval for treatment.

[Wikipedia] thiopurine drugs metabolized by TPMT include azathioprine, mercaptopurine, and thioguanine


OMIM187680
Desc
Variant0002
Relatedalso
OMIM187680
Desc
Variant0004
Relatedalso


ClinVar
Risk Rs1800460(A;A)
Alt Rs1800460(A;A)
Reference Rs1800460(G;G)
Significance Other
Disease Thiopurine methyltransferase deficiency not provided
Variation info
Gene TPMT
CLNDBN Thiopurine methyltransferase deficiency not provided
Reversed 1
HGVS NC_000006.11:g.18139228C>T
CLNSRC OMIM Allelic Variant UniProtKB (protein)
CLNACC RCV000013559.25, RCV000013561.18, RCV000309972.1,



[PMID 17366837OA-icon.png] Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada.


[PMID 18547414OA-icon.png] Genotyping panel for assessing response to cancer chemotherapy.


[PMID 18662289OA-icon.png] Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.


[PMID 18685564OA-icon.png] Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.


[PMID 22385887] High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.



[PMID 23133420OA-icon.png] Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.